Vimarsana
Biggest News Aggregation in the World

Page 8 - Multiple Sclerosis Centers News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Multiple Sclerosis Centers. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Multiple Sclerosis Centers Today - Breaking & Trending Today

Lower-dose gadolinium now being used for MRIs with contrast – Multiple Sclerosis News Today - Vimarsana News

Lower-dose gadolinium now being used for MRIs with contrast – Multiple Sclerosis News Today

Columnist Ed Tobias wonders how the new gadolinium-based contrast agent Elucirem will affect patients' comfort levels during MRIs.

Lower-dose gadolinium now being used for MRIs with contrast | Multiple Sclerosis News Today - Vimarsana News

Lower-dose gadolinium now being used for MRIs with contrast | Multiple Sclerosis News Today

Columnist Ed Tobias wonders how the new gadolinium-based contrast agent Elucirem will affect patients' comfort levels during MRIs.

Treatment Options for Multiple Sclerosis | Multiple Sclerosis News Today - Vimarsana News

Treatment Options for Multiple Sclerosis | Multiple Sclerosis News Today

No cure exists yet for multiple sclerosis, but there are several treatment options that can help manage MS symptoms, progression, and attacks.

TG Therapeutics Announces FDA Approval of BRIUMVI™ (ublituximab-xiiy) - Vimarsana News

TG Therapeutics Announces FDA Approval of BRIUMVI™ (ublituximab-xiiy)

TG Therapeutics Announces FDA Approval of BRIUMVI™ (ublituximab-xiiy) - read this article along with other careers information, tips and advice on BioSpace

TG Therapeutics Announces FDA Approval of BRIUMVI™ - Vimarsana News

TG Therapeutics Announces FDA Approval of BRIUMVI™

BRIUMVI is the first and only anti-CD20 monoclonal antibody approved for patients with relapsing forms of multiple sclerosis that can be administered in a...